| Protein processing in endoplasmic reticulum |
2.44 |
0.00e+0 |
127/171 (74.27%) |
HERPUD1;DDIT3;P4HB;...
|
| Ferroptosis |
2.24 |
0.00e+0 |
36/41 (87.8%) |
HMOX1;SLC7A11;MAP1LC3B;...
|
| Glycolysis / Gluconeogenesis |
2.18 |
0.00e+0 |
56/67 (83.58%) |
ENO2;ALDOC;HK2;...
|
| Fructose and mannose metabolism |
2.17 |
0.00e+0 |
30/33 (90.91%) |
ALDOC;HK2;PFKP;...
|
| HIF-1 signaling pathway |
2.12 |
0.00e+0 |
105/109 (96.33%) |
VEGFA;ENO2;HMOX1;...
|
| Starch and sucrose metabolism |
2.07 |
0.00e+0 |
25/36 (69.44%) |
HK2;GPI;GBE1;...
|
| Mitophagy |
2.01 |
1.70e-3 |
56/68 (82.35%) |
BNIP3;BNIP3L;ATF4;...
|
| Pentose phosphate pathway |
1.98 |
1.49e-3 |
25/30 (83.33%) |
ALDOC;PFKP;PGD;...
|
| Galactose metabolism |
1.95 |
2.65e-3 |
26/31 (83.87%) |
HK2;PFKP;GLA;...
|
| Other glycan degradation |
1.86 |
8.35e-3 |
13/18 (72.22%) |
NEU1;GLB1;MANBA;...
|
| Amino sugar and nucleotide sugar metabolism |
1.83 |
1.08e-2 |
38/48 (79.17%) |
HK2;GFPT1;GPI;...
|
| Mineral absorption |
1.83 |
9.94e-3 |
48/60 (80%) |
HMOX1;ATP1A2;ATP2B1;...
|
| Insulin resistance |
1.80 |
1.28e-2 |
96/108 (88.89%) |
SLC2A1;PCK2;GFPT1;...
|
| Cholesterol metabolism |
1.80 |
1.19e-2 |
44/50 (88%) |
SORT1;LPL;APOA1;...
|
| Insulin secretion |
1.79 |
1.27e-2 |
75/86 (87.21%) |
SLC2A1;ATF4;KCNN4;...
|
| Thyroid hormone synthesis |
1.77 |
1.42e-2 |
66/75 (88%) |
ATF4;ATP1A2;HSPA5;...
|
| Estrogen signaling pathway |
1.77 |
1.40e-2 |
119/137 (86.86%) |
TFF1;HSPA6;ATF4;...
|
| Central carbon metabolism in cancer |
1.77 |
1.32e-2 |
67/70 (95.71%) |
SLC2A1;HK2;PFKP;...
|
| Vitamin digestion and absorption |
1.77 |
1.32e-2 |
17/24 (70.83%) |
APOA1;ABCC1;APOB;...
|
| Vibrio cholerae infection |
1.77 |
1.25e-2 |
44/50 (88%) |
ERO1A;KDELR3;PDIA4;...
|
| Insulin signaling pathway |
1.74 |
1.31e-2 |
121/137 (88.32%) |
HK2;PCK2;EIF4EBP1;...
|
| Ether lipid metabolism |
1.72 |
1.79e-2 |
32/49 (65.31%) |
PLPP3;PLD3;PLPP2;...
|
| Hypertrophic cardiomyopathy |
1.71 |
2.33e-2 |
81/90 (90%) |
TNNC1;TTN;ITGB4;...
|
| TNF signaling pathway |
1.69 |
2.43e-2 |
103/112 (91.96%) |
ATF4;CCL20;JUN;...
|
| Cortisol synthesis and secretion |
1.69 |
2.53e-2 |
58/65 (89.23%) |
ATF4;PDE8B;ITPR3;...
|
| Fat digestion and absorption |
1.68 |
2.71e-2 |
35/43 (81.4%) |
PLPP3;PLPP2;APOA1;...
|
| Glycine, serine and threonine metabolism |
1.66 |
3.18e-2 |
31/40 (77.5%) |
PHGDH;CTH;SHMT2;...
|
| Renal cell carcinoma |
1.66 |
3.07e-2 |
68/69 (98.55%) |
VEGFA;SLC2A1;CDKN1A;...
|
| Legionellosis |
1.66 |
2.96e-2 |
51/57 (89.47%) |
BNIP3;HSPA6;CXCL8;...
|
| Steroid biosynthesis |
1.65 |
3.50e-2 |
19/20 (95%) |
MSMO1;SOAT1;DHCR7;...
|
| Nucleotide excision repair |
-1.63 |
3.60e-2 |
40/47 (85.11%) |
GTF2H4;RFC5;POLE;...
|
| Thermogenesis |
-1.63 |
3.88e-2 |
173/232 (74.57%) |
ACSL4;SMARCC1;NDUFB8;...
|
| Fanconi anemia pathway |
-1.67 |
3.11e-2 |
36/54 (66.67%) |
TOP3A;PALB2;FANCG;...
|
| RNA polymerase |
-1.70 |
2.53e-2 |
23/31 (74.19%) |
POLR2B;POLR2K;POLR2L;...
|
| Base excision repair |
-1.71 |
2.49e-2 |
29/33 (87.88%) |
NEIL3;POLE;POLD1;...
|
| Complement and coagulation cascades |
-1.76 |
1.62e-2 |
76/85 (89.41%) |
SERPIND1;F12;F2;...
|
| Cell cycle |
-1.78 |
1.19e-2 |
110/124 (88.71%) |
RBL2;ATM;ANAPC10;...
|
| Spliceosome |
-1.85 |
1.04e-2 |
101/150 (67.33%) |
SRSF10;SRSF3;SRSF6;...
|
| Mismatch repair |
-1.88 |
3.66e-3 |
22/23 (95.65%) |
RFC5;RPA3;RFC4;...
|
| Oxidative phosphorylation |
-1.91 |
2.92e-3 |
93/133 (69.92%) |
NDUFB8;NDUFB5;SDHB;...
|
| Systemic lupus erythematosus |
-1.92 |
3.66e-3 |
45/135 (33.33%) |
HLA-DMB;C8B;C1R;...
|
| Asthma |
-1.95 |
2.44e-3 |
25/31 (80.65%) |
HLA-DRA;PRG2;CD40;...
|
| Ribosome biogenesis in eukaryotes |
-2.16 |
0.00e+0 |
52/108 (48.15%) |
IMP3;RPP38;RPP30;...
|
| DNA replication |
-2.39 |
0.00e+0 |
34/36 (94.44%) |
POLA1;RFC5;POLE;...
|
